SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/21/19 Conmed Corp 8-K:8 11/21/19 10:179K Computershare C… Svcs/FA |
Document/Exhibit Description Pages Size 1: 8-K Current Report HTML 25K 6: R1 Cover HTML 47K 8: XML IDEA XML File -- Filing Summary XML 11K 9: XML XBRL Instance -- form8k-23069_cnmd_htm XML 14K 7: EXCEL IDEA Workbook of Financial Reports XLSX 6K 3: EX-101.LAB XBRL Labels -- cnmd-20191121_lab XML 96K 4: EX-101.PRE XBRL Presentations -- cnmd-20191121_pre XML 64K 2: EX-101.SCH XBRL Schema -- cnmd-20191121 XSD 12K 5: JSON XBRL Instance as JSON Data -- MetaLinks 25± 33K 10: ZIP XBRL Zipped Folder -- 0001174947-19-001223-xbrl Zip 10K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): i November 21, 2019
(Exact name of registrant as specified in its charter)
i New York | i 0-16093 | i 16-0977505 |
(State or other jurisdiction of | (Commission | (I.R.S. Employer |
incorporation or organization) | File Number) | Identification No.) |
(Address of principal executive offices, including zip code)
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (See General Instruction A.2 below):
i ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
i Common Stock, $0.01 par value | i CNMD | i NASDAQ |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
C:
Item 8.01 Other Events
On November 21, 2019, CONMED Corporation announced it will be paying a quarterly cash dividend of $0.20 per share on January 7, 2020 to all shareholders of record as of December 13, 2019.
C:
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 21, 2019 | CONMED CORPORATION | |
(Registrant) | ||
By: | /s/ Todd W. Garner | |
Name: | Todd W. Garner | |
Title: | Executive Vice President- | |
Chief Financial Officer |
C:
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
1/7/20 | ||||
12/13/19 | 4 | |||
Filed on / For Period end: | 11/21/19 | |||
List all Filings |